Pregnancy-Adapted YEARS Algorithm for PE – Ready for Prime Time?

Written by Anand Swaminathan REBEL EM Medical Category: Cardiovascular

Background: The clinical diagnosis of pulmonary embolism (PE) can be challenging given its variable presentation, thus requiring dependence on objective testing. Decision instruments such as PERC and the Wells’ score help stratify patients to low or high probability, enabling focused use of CT pulmonary angiography (CTPA) for diagnosis. However, despite these algorithms, there is evidence of increasing use of CTPA along with diminishing diagnostic rate (less than 10%). This combination results in the overdiagnosis of subsegmental PEs, unnecessary exposure to radiation and false positive results. These issues are compounded in patients with pregnancy. While we know that pregnancy increases risk of venous thromboembolism (VTE) our testing rates far exceed the added risk exposing thousands of women to the afore mentioned potential harms.

In 2017, the YEARS algorithm established a simplified algorithm for evaluation with a two-tiered D-dimer threshold in an effort to reduce the number of patients getting CTPA (van der Hulle 2017). The YEARS algorithm asks three questions: 1) Are there clinical signs of DVT? 2) Does the patient have hemoptysis? and 3) is PE the most likely diagnosis. If the answer to all 3 questions is no, the D-dimer threshold is set at 1000 ng/mL FEU (500 ng/mL DDU) and if the answer is “yes” to any of the 3 questions, the D-dimer threshold is set at 500 ng/mL (250 ng/mL DDU). However, this study had very few pregnant women enrolled.

Clinical Question: Can a pregnancy-adapted YEARS algorithm safely avoid diagnostic imaging in pregnant women with suspected pulmonary embolism?

Article: van der Pol LM et al. Pregnancy-Adapted YEARS Algorithm for diagnosis of Suspected Pulmonary Embolism. NEJM 2019; 380(12): 1139-49. PMID: 30893534

Population: Pregnant women > 18 years of age who had been referred to the ED or obstetrical ward for suspected PE defined as new or worsening chest pain or dyspnea with or without hemoptysis or tachycardia

Primary Outcome: Cumulative incidence of symptomatic VTE during a 3-month follow-up period in subgroup of patients in whom anticoagulation treatment was withheld on the basis of a negative YEARS algorithm

Secondary Outcome: Proportion of patients being evaluated for PE who did not require a CTPA based on the algorithm

Design: Prospective, multicenter, observational study conducted at 11 academic and 7 nonacademic hospitals.

Excluded: Treatment with a full therapeutic dose of anticoagulant initiated > 24 hours before enrollment, unavailability of patient for follow-up, allergy to iodinated contrast enhancement, life expectancy of 3 months or less

Note: The adaptation of the YEARS algorithm in pregnant women was simply that Compression US was performed in all women with symptoms of DVT and if positive, CTPA was not performed.

Pregnancy-Adapted YEARS Algorithm

Primary Results:

510 women were screened

12 (2.4%) of women screened were excluded

498 patients ultimately evaluated in this study 46% of patients in 3rd trimester of pregnancy



Critical Findings:

Total number of VTE: n = 20 (4.0% 95% CI 2.6 – 6.1) YEARS criteria negative 51% (n = 252) YEARS criteria positive 49% (n = 246) YEARS Features Hemoptysis: 7.7% (n = 19) Signs of DVT: 19% (n = 47) 7% (n = 3) + DVT study PE considered most likely diagnosis 89% (n = 218) D-Dimer Testing 39% (n = 195) below threshold for further testing 61% (n = 299) above threshold (required further testing) CTPA (n = 273) positive in 15 patients V/Q Scan (n = 2) positive in 1 patient Protocol violation: 24 patients had no imaging 1 patient was YEARS criteria negative but D-Dimer + Primary Outcome (VTE at 3 months) n = 477 (96%) PE ruled out at baseline n = 476 with no symptomatic VTE at 3 months n = 1 VTE during follow up 0.21% (95% CI -.04 – 1.2) Patient had symptomatic popliteal DVT diagnosed on day 90 Secondary Outcome n = 195 patients who were ruled out based on adapted YEARS n = 12 (6.2%) underwent CTPA (protocol violation) All 12 negative for PE CTPA could safely be avoided in 39% of patients (95% CI 35-44)



Strengths:

Study asks a clinically important question addressing a shortcoming of the parent study (i.e. original YEARS study had very few pregnant women enrolled)

Multicenter study increasing external validity

Screened patients consecutively for enrollment

Follow up was excellent with only 1 patient temporarily lost to follow up (ultimately, was found)

Enrolled women in 1st, 2nd, and 3rd trimester of pregnancy

An independent committee assessed and adjudicated all suspected cases of VTE and deaths that occurred during follow up

Limitations:

Only enrolled patients in Netherlands and France decreasing external validity

All patients were not tested for VTE and, thus, some VTE may have been missed

All hospitals used D-dimer assays using FEU (no mention of assays using DDU)

Protocol violations were present and in greater numbers in group in which algorithm directed clinicians towards CTPA

Due to the parallel timing of the assessment of YEARS criteria and the measurement of the D-Dimer level, physicians may have occasionally been aware of the D-Dimer result when they were assessing the YEARS criteria which may have biased the evaluation of patients

Patients underwent 2-point compression ultrasonography of the deep veins of the symptomatic leg (at the popliteal and inguinal levels) to confirm or rule out proximal DVT. Using this strategy may have missed some DVTs between these two areas.

Discussion:

Study adaptation was pragmatic – pregnant women with confirmed DVT do not require CTPA since it would not change management but would expose the patient and fetus to radiation

YEARS criteria are simple to remember as there are only 3 of them and the D-Dimer cutoffs are simple as well

Not all patients had a CTPA performed and, thus, some PEs may have been missed. However, the lack of symptoms prompting further assessment and diagnosis of VTE at 3 months in almost all patients means that PEs missed were very likely to be clinically irrelevant

The overall prevalence of VTE was low in this cohort (~ 4%) but, the rate is consistent with prior published reports that have shown a prevalence of PE of <5% among pregnant patients in whom PE is suspected, as compared to 15 – 20% in non-pregnant patients

It would be interesting to add a trimester-adjusted d-dimer threshold to this algorithm ( UMEM Pearls ) which could further reduce the need for CTPA

The efficiency of the algorithm was highest during the first trimester of pregnancy and the lowest during the third trimester of pregnancy; CTPA was avoided in 65% who began the study in the first trimester of pregnancy and in 32% who began the study in the third trimester of pregnancy

The definition of PE was a new filling defect in a subsegmental or more proximal pulmonary artery, however, sub segmental PEs may be clinically insignificant

One of the three YEARS criteria is subjective in nature – “PE as the most likely diagnosis” This subjective criterion makes application more challenging Most common feature of those who had > 1 YEARS criteria (89%) Difficult to know if gestalt of this group of clinicians is similar to overall gestalt In countries were testing is more conservative (i.e. US) the reduction in testing may be less dramatic because of this



Authors Conclusions: “Pulmonary embolism was safely ruled out by the pregnancy-adapted YEARS diagnostic algorithm across all trimesters of pregnancy. CT pulmonary angiography was avoided in 32 to 65% of patients.”

Our Conclusions: Overall, we agree with the authors conclusions. The pregnancy-adapted YEARS algorithm safely ruled out PE in this cohort of patients with a small risk of VTE at 3 months if the patient was negative on initial visit.

Potential to Impact Current Practice: External validation of this approach is needed but, application of the pregnancy-adapted YEARS algorithm has the potential to safely decrease CTPA use in pregnant women in whom the clinician has a concern for PE.

Bottom Line: The Pregnancy-Adapted YEARS algorithm has both face validity and is pragmatic for clinical practice. However, before implementation of this algorithm into everyday practice, an external validation study would be warranted.

For More on this Topic Checkout:

References:

van der Hulle T et al. Simplified diagnostic management of suspected pulmonary embolism (the YEARS study): a prospective multicentre, cohort study. Lancet 2017; 390: 289-97. PMID: 28549662

Post Peer Reviewed By: Salim R. Rezaie, MD (Twitter: @srrezaie)